Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Orthopedic Oncology received 61 citations as per Google Scholar report
Targeted therapy in bone sarcomas involves using drugs or other substances that specifically target the molecular abnormalities driving the growth of bone tumors. This approach aims to inhibit tumor progression while minimizing damage to healthy tissue.
Targeted therapy in bone sarcomas focuses on addressing specific genetic mutations or molecular pathways that are crucial for tumor survival and growth. By selectively targeting these abnormalities, targeted therapies offer a more precise treatment option compared to traditional chemotherapy. This strategy can improve treatment efficacy, reduce side effects, and enhance overall outcomes for patients with bone sarcomas, making it a key component of modern cancer care in orthopedic oncology.